GW&K Investment Management’s Federal Realty Investment Trust FRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11K Sell
89
-4
-4% -$465 ﹤0.01% 890
2026
Q1
$10K Hold
93
– – ﹤0.01% 870
2025
Q4
$9K Hold
93
– – ﹤0.01% 868
2025
Q3
$9K Sell
93
-24
-21% -$2.32K ﹤0.01% 872
2025
Q2
$11K Buy
117
+29
+33% +$2.74K ﹤0.01% 830
2025
Q1
$9K Sell
88
-5
-5% -$520 ﹤0.01% 825
2024
Q4
$10K Hold
93
– – ﹤0.01% 772
2024
Q3
$11K Hold
93
– – ﹤0.01% 755
2024
Q2
$9K Buy
93
+10
+12% +$1.01K ﹤0.01% 754
2024
Q1
$8K Hold
83
– – ﹤0.01% 754
2023
Q4
$9K Buy
83
+4
+5% +$377 ﹤0.01% 700
2023
Q3
$7K Buy
79
+52
+193% +$5.12K ﹤0.01% 710
2023
Q2
$3K Buy
+27
New +$2.54K ﹤0.01% 819
2022
Q3
– Sell
-16
Closed -$2K – 566
2022
Q2
$2K Sell
16
-3
-16% -$337 ﹤0.01% 751
2022
Q1
$2K Buy
+19
New +$2.34K ﹤0.01% 699
2020
Q4
– Sell
-40
Closed -$3K – 391
2020
Q3
$3K Buy
+40
New +$3.15K ﹤0.01% 368

Other funds holding FRT

GW&K Investment Management's FRT Position: Q2 2026 in Review

GW&K Investment Management reduced its Federal Realty Investment Trust (FRT) stake by 4.3% in Q2 2026, selling an estimated $465 and leaving 89 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #890.

GW&K Investment Management first reported a position in FRT in Q3 2020 and has held it in 16 quarters since. 623 funds tracked by Wall St. Rank hold FRT as of Q2 2026.

  • GW&K Investment Management held 89 shares of Federal Realty Investment Trust worth $11K as of Q2 2026.
  • GW&K Investment Management sold 4 Federal Realty Investment Trust shares in Q2 2026, an estimated $465.
  • Federal Realty Investment Trust made up ﹤0.01% of GW&K Investment Management's portfolio in Q2 2026, its #890 holding.
  • GW&K Investment Management first reported a position in Federal Realty Investment Trust in Q3 2020 and has held it in 16 quarters since.
  • 623 funds tracked by Wall St. Rank held Federal Realty Investment Trust as of Q2 2026.

Based on GW&K Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.